These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2468349)

  • 1. Inhibition of HIV and virus replication by polysulphated polyxylan: HOE/BAY 946, a new antiviral compound.
    Biesert L; Suhartono H; Winkler I; Meichsner C; Helsberg M; Hewlett G; Klimetzek V; Mölling K; Schlumberger HD; Schrinner E
    AIDS; 1988 Dec; 2(6):449-57. PubMed ID: 2468349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polysulphated polyxylan Hoe/Bay-946 inhibits HIV replication on human monocytes/macrophages.
    von Briesen H; Meichsner C; Andreesen R; Esser R; Schrinner E; Rübsamen-Waigmann H
    Res Virol; 1990; 141(2):251-7. PubMed ID: 2345812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-human immunodeficiency virus (HIV) drug HOE/BAY946 increases membrane hydrophobicity of human lymphocytes and specifically suppresses HIV-protein synthesis.
    Biesert L; Adamski M; Zimmer G; Suhartono H; Fuchs J; Unkelbach U; Mehlhorn RJ; Hideg K; Milbradt R; Rübsamen-Waigmann H
    Med Microbiol Immunol; 1990; 179(6):307-21. PubMed ID: 1965549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hoe/Bay 946--a new compound with activity against the AIDS virus.
    Wagner WH
    Arzneimittelforschung; 1989 Jan; 39(1):112-3. PubMed ID: 2719738
    [No Abstract]   [Full Text] [Related]  

  • 5. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of avian myeloblastosis virus reverse transcriptase activity by HOE/BAY 946, a polysulphated polysaccharide.
    Sumida KT; Chuang LF; Cheung AT; Killam KF; Chen MS; Chuang RY
    Proc West Pharmacol Soc; 1990; 33():105-9. PubMed ID: 1703305
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium pentosan polysulfate (PPS), an anti-HIV agent also exhibits synergism with AZT, lymphoproliferative activity, and virus enhancement.
    Anand R; Nayyar S; Galvin TA; Merril CR; Bigelow LB
    AIDS Res Hum Retroviruses; 1990 May; 6(5):679-89. PubMed ID: 1694454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of a lichen polysaccharide sulfate, GE-3-S, on the replication of human immunodeficiency virus (HIV) in vitro.
    Hirabayashi K; Iwata S; Ito M; Shigeta S; Narui T; Mori T; Shibata S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2410-2. PubMed ID: 2575016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
    Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
    Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of HIV infectivity by the chlorite-oxygen reaction product tetrachlorodecaoxygen.
    Ennen J; Werner K; Kühne FW; Kurth R
    AIDS; 1993 Sep; 7(9):1205-12. PubMed ID: 8216977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro.
    Baba M; Nakajima M; Schols D; Pauwels R; Balzarini J; De Clercq E
    Antiviral Res; 1988 Sep; 9(6):335-43. PubMed ID: 2465736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of HIV inhibition by modified antisense oligonucleotides.
    Abramova T; Blinov V; Vlassov V; Gorn V; Zarytova V; Ivanova E; Konevets D; Plyasunova O; Pokrovsky A; Sandakhchiev L
    Nucleic Acids Symp Ser; 1991; (24):283. PubMed ID: 1841341
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
    Ichimura H; Levy JA
    Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.
    Nakashima H; Masuda M; Murakami T; Koyanagi Y; Matsumoto A; Fujii N; Yamamoto N
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1249-55. PubMed ID: 1384424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes.
    Bergamini A; Perno CF; Balzarini J; Capozzi M; Marinelli L; Milanese G; Pesce CD; Calió R; Rocchi G
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1239-47. PubMed ID: 1381599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation.
    Baba M; Schols D; De Clercq E; Pauwels R; Nagy M; Györgyi-Edelényi J; Löw M; Görög S
    Antimicrob Agents Chemother; 1990 Jan; 34(1):134-8. PubMed ID: 2327749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assessment of compounds for anti-HIV activity.
    Patience C; Moore J; Boyd M
    Mol Biotechnol; 1994 Feb; 1(1):49-58. PubMed ID: 7532100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphoevernan, a polyanionic polysaccharide, and the narcissus lectin potently inhibit human immunodeficiency virus infection by binding to viral envelope protein.
    Weiler BE; Schröder HC; Stefanovich V; Stewart D; Forrest JM; Allen LB; Bowden BJ; Kreuter MH; Voth R; Müller WE
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():1957-63. PubMed ID: 2212988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.